ABSI logo

Absci (ABSI)

Profile

Full Name

Absci Corporation

Ticker Symbol

ABSI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 22, 2021

Indexes

Not included

Website

http://www.absci.com

Employees

156

Key Details

Price

$2.40

Market Cap

$305.60M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$4.53M(-20.71% YoY)

Annual EPS

-$0.94(+21.67% YoY)

PE Ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.40
ABSI price is $2.40

Price All-time High

$30.29
ABSI price is currently -92.08% below its historical high of $30.29

Price Most Recent Change

-4.76%
ABSI price was down -4.76% on Apr 1, 2025

Price YTD Change

-9.77%
ABSI price is down -9.77% since January 1st

Price 1-year Change

-57.37%
ABSI price is down -57.37% year-on-year

Price 3-year Change

-72.79%
ABSI price is down -72.79% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$305.60M
ABSI market capitalization is $305.60 million

Market Cap 3-year Change

-62.68%
ABSI market capitalization is down -62.68% over the past 3 years

Market Cap All-time High

$2.79B
ABSI market capitalization is currently -89.06% below its historical high of $2.79 billion

Market Cap Sector Rank

62.64%
ABSI market capitalization is higher than 62.64% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+12.69%
ABSI shares outstanding is up +12.69% year-on-year

Shares Outstanding 3-Year Change

+37.16%
ABSI shares outstanding is up +37.16% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-
ABSI beta value is unknown

200-day SMA

$3.69
ABSI price is currently -35.02% below its 200-day simple moving average

50-day SMA

$3.80
ABSI price is currently -36.81% below its 50-day simple moving average

RSI

-
ABSI 14-day relative strength index value is unknown

Volume

0.98
ABSI 30-day relative volume is 0.98

ATR

-
ABSI average true range value is unknown

10-day Historical Volatility

-
ABSI 10-day historical volatility value is unknown

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.53M
ABSI annual revenue is $4.53 million

Revenue Analysts Estimate

$11.39M
ABSI annual revenue is currently -60.21% lower than the consensus analysts' forecast

Revenue 1-year Change

-20.71%
ABSI annual revenue is down -20.71% year-on-year

Revenue Sector Rank

22.47%
ABSI annual revenue is higher than 22.47% of companies in Healthcare sector

EPS

EPS

-$0.94
ABSI annual earnings per share is -$0.94

EPS Analysts Estimate

-$0.89
ABSI annual earnings per share is currently +6.13% higher than the consensus analysts' forecast

EPS 1-year Change

+21.67%
ABSI annual earnings per share is up +21.67% year-on-year

EPS Sector Rank

58.82%
ABSI annual earnings per share is higher than 58.82% of companies in Healthcare sector

Profit

Gross Profit

-
ABSI annual gross profit value is unknown

Gross Margin

-
ABSI annual gross profit margin value is unknown

Operating Profit

-$108.89M
ABSI annual operating income is -$108.89 million

Operating Margin

-2401.59%
ABSI annual operating profit margin is -2401.59%

Net Income

-$103.11M
ABSI annual net profit is -$103.11 million

Net Margin

-2274.06%
ABSI annual net profit margin is -2274.06%

Expenses

Total Expenses

$113.42M
ABSI annual total expenses is $113.42 million

Operating Expenses

$113.42M
ABSI annual total operating expenses is $113.42 million

Cost Of Goods Sold

-
ABSI annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$36.17M
ABSI annual SGA is $36.17 million

Depreciation And Amortization

$13.39M
ABSI annual depreciation & amortization is $13.39 million

Interest Expense

$565.00K
ABSI annual interest expense is $565.00 thousand

Income Tax

$70.00K
ABSI annual income tax is $70.00 thousand

EBIT & EBITDA

EBIT

-$102.47M
ABSI annual earnings before interest & taxes is -$102.47 million

EBITDA

-$89.08M
ABSI annual EBITDA is -$89.08 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$213.61M
ABSI annual total assets is $213.61 million

Non Current Assets

$79.78M
ABSI annual long term assets is $79.78 million

Current Assets

$133.83M
ABSI annual total current assets is $133.83 million

Cash And Cash Equivalents

$41.21M
ABSI annual cash & cash equivalents is $41.21 million

Accounts Receivable

$0.00
ABSI annual accounts receivable is $0.00

Inventory

-
ABSI annual inventory value is unknown

Liabilities

Total Liabilities

$34.48M
ABSI annual total liabilities is $34.48 million

Long Term Liabilities

$5.82M
ABSI annual total long term liabilities is $5.82 million

Current Liabilities

$28.66M
ABSI annual total current liabilities is $28.66 million

Accounts Payable

$3.53M
ABSI annual accounts payable is $3.53 million

Debt

Total Debt

$10.11M
ABSI annual total debt is $10.11 million

Total Debt 1-year Change

-36.37%
ABSI annual total debt is down -36.37% year-on-year

Long Term Debt

$5.69M
ABSI annual long term debt is $5.69 million

Short Term Debt

$4.42M
ABSI annual short term debt is $4.42 million

Equity & Capital

Shareholders Equity

$179.13M
ABSI annual stockholders equity is $179.13 million

Book Value

$179.13M
ABSI annual book value is $179.13 million

Retained Earnings

-$509.60M
ABSI annual retained earnings is -$509.60 million

Working Capital

$105.17M
ABSI annual working capital is $105.17 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$72.40M
ABSI annual cash flow from operations is -$72.40 million

Cash From Operations 1-year Change

-12.01%
ABSI annual cash flow from operations is down -12.01% year-on-year

Cash From Investing

-$41.58M
ABSI annual cash flow from investing activities is -$41.58 million

Cash From Investing 1-year Change

-150.74%
ABSI annual cash flow from investing activities is down -150.74% year-on-year

Cash From Financing

$82.53M
ABSI annual cash flow from financing activities is $82.53 million

Cash From Financing 1-year Change

+1940.87%
ABSI annual cash flow from financing activities is up +1940.87% year-on-year

CAPEX

CAPEX

$404.00K
ABSI annual capital expenditures is $404.00 thousand

CAPEX 1-year Change

-53.02%
ABSI annual capital expenditures is down -53.02% year-on-year

Free Cash Flow

Free Cash Flow

-$72.81M
ABSI annual free cash flow is -$72.81 million

Free Cash Flow 1-year Change

-11.16%
ABSI annual free cash flow is down -11.16% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
ABSI annual gross profit margin value is unknown

Operating Margin

-2401.59%
ABSI annual operating profit margin is -2401.59%

Net Margin

-2274.06%
ABSI annual net profit margin is -2274.06%

ROA & ROE

ROA

-47.86%
ABSI annual return on assets is -47.86%

ROE

-58.04%
ABSI annual return on equity is -58.04%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ABSI price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ABSI price to earnings ratio is unknown

PB Ratio

PB Ratio

1.71
ABSI price to book ratio is 1.71

PB Ratio Sector Rank

57.9%
ABSI price to book ratio is higher than 57.9% of companies in Healthcare sector

PS Ratio

PS Ratio

67.40
ABSI price to sales ratio is 67.40

PS Ratio Sector Rank

93.24%
ABSI price to sales ratio is higher than 93.24% of companies in Healthcare sector

Enterprise value

Enterprise Value

$274.49M
ABSI enterprise value is $274.49 million

Enterprise Value Sector Rank

62.26%
ABSI enterprise value is higher than 62.26% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.08
ABSI EV/EBITDA is -3.08

EV/EBITDA Sector Rank

27.51%
ABSI EV/EBITDA is higher than 27.51% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

4.67
ABSI annual current ratio is 4.67

Quick Ratio

-
ABSI annual quick ratio value is unknown

Leverage

Debt To Equity

0.02
ABSI annual debt to equity ratio is 0.02

Interest Coverage Ratio

-181.36
ABSI annual interest coverage ratio is -181.36

Risk & Stability

Piotroski F-Score

-
ABSI piotroski f-score value is unknown

Altman Z-Score

1.01
ABSI altman z-score is 1.01

Analyst ratings

Recent major analysts updates

Mar 20, 25 Guggenheim
Buy
Mar 19, 25 Needham
Buy
Mar 19, 25 HC Wainwright & Co.
Buy
Jan 22, 25 Needham
Buy
Jan 17, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 8, 25 Keybanc
Overweight
Jan 8, 25 HC Wainwright & Co.
Buy
Dec 13, 24 HC Wainwright & Co.
Buy
Dec 3, 24 Guggenheim
Buy

Institutional Ownership

Similar stocks

VSTM logo
Verastem (VSTM)
DH logo
Definitive Healthcare (DH)
ATXS logo
Astria Therapeutics (ATXS)
HCAT logo
Health Catalyst (HCAT)
ALLO logo
Allogene Therapeutics (ALLO)
CMPX logo
Compass Therapeutics (CMPX)
RIGL logo
Rigel Pharmaceuticals (RIGL)
AURA logo
Aura Biosciences (AURA)
Tectonic Therapeutic (TECX)
  • What is the ticker symbol for Absci?
  • Does Absci pay dividends?
  • What sector is Absci in?
  • What industry is Absci in?
  • What country is Absci based in?
  • When did Absci go public?
  • Is Absci in the S&P 500?
  • Is Absci in the NASDAQ 100?
  • Is Absci in the Dow Jones?
  • When was Absci's last earnings report?
  • When does Absci report earnings?
  • Should I buy Absci stock now?

What is the ticker symbol for Absci?

The ticker symbol for Absci is NASDAQ:ABSI

Does Absci pay dividends?

No, Absci does not pay dividends

What sector is Absci in?

Absci is in the Healthcare sector

What industry is Absci in?

Absci is in the Biotechnology industry

What country is Absci based in?

Absci is headquartered in United States

When did Absci go public?

Absci's initial public offering (IPO) was on July 22, 2021

Is Absci in the S&P 500?

No, Absci is not included in the S&P 500 index

Is Absci in the NASDAQ 100?

No, Absci is not included in the NASDAQ 100 index

Is Absci in the Dow Jones?

No, Absci is not included in the Dow Jones index

When was Absci's last earnings report?

Absci's most recent earnings report was on Mar 18, 2025

When does Absci report earnings?

The next expected earnings date for Absci is May 14, 2025

Should I buy Absci stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page